NANOBIOTIX (EPA:NANO) | Finanzwire

Basculer en Français

10591	Companies
224574	Keywords
153308	Articles
118793	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 11/13/2025 at 22:15, 7 months 4 days ago

NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations
Nanobiotix announces advancements in Curadigm Nanoprimer platform with new patent applications, pre-clinical data, and external collaborations, aiming to revolutionize drug delivery

Pre-clinical Data Patent Applications NANOBIOTIX Curadigm Nanoprimer External Collaborations
BRIEF

published on 11/11/2025 at 22:20, 7 months 6 days ago

Nanobiotix will participate in the Jefferies London Healthcare conference

Biotechnology Oncology NANOBIOTIX Nanoparticles Jefferies Conference
PRESS RELEASE

published on 11/11/2025 at 22:15, 7 months 6 days ago

NANOBIOTIX to Participate in Jefferies London Healthcare Conference
Nanobiotix to participate in Jefferies London Healthcare Conference on Nov 17, 2025, with company management as presenters. Webcast available. Learn about Nanobiotix and its disruptive therapeutic approaches

Webcast Nanotechnology NANOBIOTIX Therapeutic Approaches Jefferies London Healthcare Conference
BRIEF

published on 10/31/2025 at 08:05, 7 months 17 days ago

Nanobiotix Secures $71 Million Agreement with HealthCare Royalty

Long-term Growth HealthCare Royalty NANOBIOTIX Royalty Agreement Oncology Development
PRESS RELEASE

published on 10/31/2025 at 08:00, 7 months 17 days ago

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth
Nanobiotix announces $71M strategic royalty monetization agreement with Healthcare Royalty, extending cash runway and enabling long-term growth in cancer treatment

Cancer Treatment HealthCare Royalty Financial Agreement NANOBIOTIX Royalty Monetization
BRIEF

published on 10/01/2025 at 22:20, 8 months 16 days ago

NANOBIOTIX Reveals Promising Phase 1 Study Results for Esophageal Cancer Treatment

Phase 1 Study Radiotherapy Adverse Events JNJ-1900 (NBTXR3) Esophageal Cancer
PRESS RELEASE

published on 10/01/2025 at 22:15, 8 months 16 days ago

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer
Nanobiotix announces first data from Phase 1 study evaluating JNJ-1900 (NBTXR3) for patients with esophageal cancer. Results presented at ASTRO 2025 Annual Meeting

NANOBIOTIX Phase 1 Study JNJ-1900 Esophageal Cancer ASTRO
BRIEF

published on 09/30/2025 at 22:20, 8 months 17 days ago

Nanobiotix: Financial results and clinical progress in the first half of 2025

Financial Results Biotechnology NANOBIOTIX Johnson & Johnson JNJ-1900
PRESS RELEASE

published on 09/30/2025 at 22:15, 8 months 17 days ago

NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results
Nanobiotix provides business update & reports 2025 half year financial results. Highlights clinical development program & financial performance

Financial Results Financial Performance Business Update Clinical Development NANOBIOTIX
BRIEF

published on 09/30/2025 at 00:35, 8 months 18 days ago

NANOBIOTIX Reports Promising Phase 1 Results for JNJ-1900 (NBTXR3) in R/M-HNSCC

Phase 1 Trial NANOBIOTIX Clinical Study Results R/M-HNSCC JNJ-1900 (NBTXR3)

Accesswire

Published on 06/18/2026 at 00:00, 1 hour 34 minutes ago

LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 2 hours 4 minutes ago

Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 2 hours 44 minutes ago

International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 3 hours 4 minutes ago

Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 8 hours 39 minutes ago

Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors

View all ACCESSWIRE

EQS Group

Published on 06/17/2026 at 21:40, 3 hours 53 minutes ago

Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 6 hours 24 minutes ago

Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 6 hours 54 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 18:36, 6 hours 58 minutes ago

BILENDI: Bilendi announces that Euroland Corporate has initiated coverage of its shares
Published on 06/17/2026 at 18:23, 7 hours 11 minutes ago

EQS-Adhoc: Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG: Conclusion of a delisting agreement with Bayerische Gewerbebau AG

Les Echos

Published on 06/17/2026 at 17:40, 7 hours 54 minutes ago

Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 16 hours 49 minutes ago

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 13 hours ago

Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 2 hours ago

BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 6 hours ago

Reporting on share buyback transactions carried out between June 8 and June 11, 2026

View all LES ECHOS COMFI WIRE